what is Alecensa (by AI)

 Alecensa (generic name: alectinib) is a prescription medication used to treat non-small cell lung cancer (NSCLC) that is ALK-positive. It is a targeted therapy designed to inhibit the activity of the anaplastic lymphoma kinase (ALK) gene, which can drive the growth of certain types of cancer cells.


🧬 How Alecensa Works

Alecensa is a tyrosine kinase inhibitor (TKI) that specifically targets and blocks the activity of the ALK protein. In patients with ALK-positive NSCLC, this protein can promote cancer cell proliferation. By inhibiting ALK, Alecensa helps to prevent the growth and spread of cancer cells.​WSJ+7Cancer Research UK+7alecensa+7


💊 Indications

Alecensa is approved for:

  • Adjuvant treatment: To help prevent the recurrence of early-stage (stage IB to IIIA) ALK-positive NSCLC after surgical tumor resection.WSJ+4Wikipedia+4alecensa+4

  • Metastatic treatment: For patients with advanced or metastatic ALK-positive NSCLC.


📋 Dosage and Administration

  • Standard dose: 600 mg taken orally twice daily with food.Medical News Today

  • Capsule form: Each capsule contains 150 mg of alectinib. Patients typically take four 150 mg capsules per dose.alecensa

  • If side effects occur, the dosage may be adjusted to 450 mg or 300 mg twice daily.Medical News Today


⚠️ Side Effects

Common side effects include:

Serious side effects may include:

  • Liver damage (e.g., jaundice, nausea, dark urine)

  • Severe muscle pain or weaknessalecensa+1Medscape+1

  • Lung problems (e.g., shortness of breath, cough)

  • Heart issues (e.g., slow heart rate)

  • Low red blood cell count (anemia)

Regular monitoring of liver function and blood counts is recommended during treatment.


🧪 Testing and Monitoring

Before starting treatment, patients should undergo testing to confirm the presence of the ALK gene mutation. Regular follow-up appointments are necessary to monitor for side effects and assess treatment efficacy.


🌍 Availability and Access

Alecensa is approved in over 100 countries, including the United States, Japan, and members of the European Union. In the U.S., it is marketed by Genentech, a member of the Roche Group.WSJ

تعليقات

المشاركات الشائعة من هذه المدونة

Tips on how to write a meta-analysis by Dr. Nehad Jaser

Centers for Disease Control and Prevention (CDC) categorizes germs into three main categories

The history of herbal medicine